[Anti-hypertensive treatment for primary and secondary prevention of brain attack and failure]
1Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences.
Insights
Anti-hypertensive treatment is safe and effective for preventing recurrent stroke and cognitive decline. Recent trials confirm its importance in managing hypertension-related brain changes.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Context:
- Debate exists regarding the safety and efficacy of antihypertensive treatment for secondary stroke prevention.
- Chronic stroke patients require effective strategies to prevent recurrent events and disability.
- Hypertension significantly impacts brain pathophysiology, necessitating targeted interventions.
Purpose:
- To review the efficacy and safety of antihypertensive treatments in preventing recurrent stroke.
- To evaluate the role of blood-pressure-lowering treatments in primary prevention of cognitive impairment and dementia.
- To discuss recent clinical trial findings in the context of hypertension-induced brain changes.
Summary:
- The PROGRESS trial demonstrated that antihypertensive treatment is safe and effective for preventing recurrent stroke in chronic stroke patients.
- Additional trials (HOPE, Syst-Eur2, SCOPE) support the critical role of antihypertensive therapy in preventing cognitive impairment and dementia.
- Evidence suggests a strong link between hypertension and pathophysiological brain changes, underscoring the need for effective blood-pressure management.
Impact:
- Confirms the benefit of antihypertensive therapy for secondary stroke prevention, reducing recurrence and disability.
- Highlights the crucial role of blood-pressure control in mitigating cognitive decline and dementia risk.
- Provides a comprehensive overview of recent evidence, informing clinical practice and future research on hypertension and brain health.
Abstract:
Although anti-hypertensive treatment is known to be effective for preventing first-ever stroke, there has been a long debate, whether this treatment is safe and effective for preventing recurrent stroke and subsequent disabled conditions. PROGRESS trial was designed to clarify these concerns about the efficacy and safety of blood-pressure-lowering treatments for the chronic stroke patients and clearly showed that anti-hypertensive treatment should be quite safe and effective for preventing recurrent stroke. The results of other clinical trials such as HOPE, Syst-Eur2 and SCOPE also suggested the at most importance of anti-hypertensive treatment for primary prevention of cognitive impairment and dementia. In this review, the significance of recent clinical trials were fully discussed in relation to the hypertension-induced pathophysiological changes of the brain.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Alzheimer's Disease: Treatment
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Direct Renin Inhibitors

